Introduction
Topically applied ophthalmic formulations such as eye drops are usually used to treat eye disorders such as glaucoma. In addition, novel ophthalmic implants, which are injected subconjunctivally or intrasclerally, releasing their drug substances locally, are one of the main focuses of research and development [1] . For preclinical testing of such dosage forms in vitro-dissolution test methods are needed that are capable of simulating some relevant in vivo-conditions. In this study a multi-layer diffusion cell (MDC) was developed to simulate drug release and the distribution from injections or implants, which are injected under the conjunctiva or intrascleral. By the new setup of the MDC, the effect of the choroidal and conjunctival blood flow on drug distribution will be investigated. Furthermore, the applicability of the MDC for the determination of diffusion coefficients was examined.
Methods

Multi-layer diffusion cell
The newly developed diffusion cell is composed of 3 layers, which are placed on top of each other. The layers are fixed in place by set screws (Fig. 1) . The upper and lower layers contain a flow channel each. In the middle part of the MDC the object of study (solutions or implants) can be placed. The sample space is separated from the buffer flowing through the flow channels by means of two membranes. The volume and the contact area of the upper flow channel were set to half of the volume and area of the lower flow channel to consider the proportion of the choroidal and the conjunctival blood vessels. The thickness of the diffusion layer is 3 mm. The MDC can be heated to 37°C in a water bath. The applicability of the MDC to determine diffusion coefficients (DC) was investigated. The DC of a fluorescein solution (600 µg/L in standard ringer buffer) was determined (n=5). Opposed to the perfusion study two flow channels with identical volume and area were used. A polyacrylamide gel (2% V/V), composed of standard ringer buffer, a 30 percentage solution of acryl amide, ammonium persulfate and tetramethylethylenediamine, was inserted in the central layer of the diffusion cell as the diffusion barrier. The gel was veri-fied and used as substitute for the vitreous body in a previous study [2] . To hold the gel in position, the sample reservoir was separated from the flow channels by two cellulose nitrate membranes (pore size 3 µm). The donor medium and the acceptor medium (standard Ringer buffer) were pumped separately through the respective flow channels at a flow rate of 1.0 mL/min. The perfusion occurred in a closed loop. The media (150 mL) inside the containers were continuously mixed via a magnetic stirrer. Over a period of 8 hours samples of 250 µl were taken from the acceptor medium and quantified by a fluorescence reader (Varioskan Flash Multimode Reader; Thermo Scientific /Fisher) by an excitation wavelength of 485 nm and emission wavelength of 538 nm. Afterwards the diffusion coefficient was calculated using the following equation
in which dm/dt means the mass transport per time, d the thickness of diffusion barrier (mm), A the effective area for the diffusion (mm²) and c the initial concentration (µg/mm³) in the donor medium.
Results and Discussion
Multi-layer diffusion cell Drug-loaded subconjunctival and intrascleral injections and implants are currently developed in order to serve as an alternative to the permanent topical administration of eye drops. The purpose of the development of the MDC and the studies presented here is to develop a system which is capable of simulating some of the critical parameters that influence drug release and distribution in vivo. Therefore, the relationship and influences of the different ocular blood systems such as flow rates can be studied (see below). In previous work [4] permeability coefficients of different drugs for porcine eye tissues were determined. For the in vitro setup, synthetic membranes with diffusion properties corresponding to the natural tissues have to be identified. Using these membranes as diffusion barriers within the MDC in between which the dosage form can be placed will allow for the analysis of drug release and distribution from implants with injected in the subconjunctival or intrascleral region under biorelevant conditions.
Perfusion study
The aim of this part of the study was to implement the opportunity to simulate the choroidal and conjunctival blood flow in a simplified setup. The choroidal blood flow has been reported to amount to 0.6 mL/min whereas for the conjunctival blood flow a rate of 0.2 mL/min is assumed [3] . In order to obtain these flow rates using a single multi-channel pump, different combinations of tube diameters and pumping speeds were evaluated. The intended flow rates were achieved using an adjusted flow rate of 0.6 mL/min for the tube with 1.85 mm inner diameter. Corresponding, a flow rate of 0.2 mm for the tube with 0.89 mm inner diameter was obtained. Using these parameters flow rates that correspond to the reported in vivo values were achieved.
Determination of the diffusion coefficient of fluorescein sodium in polyacrylamide gel
The DC of fluorescein sodium in a 2 % (V/V) polyacrylamide gel was determined successfully using the MDC. After an experimental lag time of 45.7 ± 8.6 minutes, a time-dependently increasing amount of the fluorescein solution was detected in the acceptor medium. The experiment was terminated after 8 hours.
For the gel a diffusion coefficient of 3.9 ± 0.2 x 10 -4 mm²/s was calculated by equation 1. The low standard deviation indicates that the MDC is suitable to perform such studies reliably. Another advantage of the MDC is that only a small sample quantity (approximately 1.5 mL) is necessary. In the sample chamber of the MDC various other media can be placed as barriers and investigated regarding their diffusion behavior which makes this model also a promising tool for dosage forms.
